Research results on advanced cancer treatment published in renowned medical journal

The world-leading medical journal Science Translational Medicine publishes research results from Oblique Therapeutics and Karolinska Institute on a new treatment of advanced cancer. The research article is titled Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.

Read the full article here: Link

Oblique Therapeutics has yet again received grants from Vinnova

This year we received funding for 3 different development projects:

  • A new class of selective antagonistic TRPV1 for pain therapyA project we continue to get funded for.
    In collaboration with KI.
  • Engineering of nano-sized membrane vesicles for intracellular delivery of therapeutic antibodiesDesigning a new technology to get antibodies inside the cell
    A project in collaboration with KTH, KI and SLU
  • Improved cancer diagnostic and drug developmentA project in collaboration with RISE among others